Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-22

FDA Approved: AMLODIPINE AND ATORVASTATIN — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals' fixed-dose combination of amlodipine and atorvastatin under an original ANDA application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and Atorvastatin (amlodipine besylate and atorvastatin calcium)

Snippet

ORIG AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)